Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Correction — Privo Technologies

company developing localized therapies for solid tumors using its proprietary nanoengineered delivery platform, focused on improving outcomes while preserving quality of life. For more information please visit, www.privotechnologies.com

HanchorBio Partners with WuXi Biologics to Advance Next-Generation Fusion Protein Pipeline

development and manufacturing services, including cell line development, process and bioassay development, drug product formulation development, and GMP manufacturing. The collaboration is designed to accelerate clinical translation, enhance CMC...

CoreAge Rx broadens GLP-1 access in support of New Year weight loss initiatives

access to specialized in-person providers. As part of the New Year's expansion, CoreAge Rx is enhancing its digital platform, strengthening patient education resources, and optimizing fulfillment processes to ensure consistent medication...

OCuSOFT Inc. introduces Retaine® Omega Forté™, a liquid supplement designed to deliver superior nutritional support in the management of dry eye

cleansing agent, proudly announces the launch of Retaine® Omega Forté™, a highly purified omega-3 nutritional supplement formulated to provide superior support for individuals suffering from dry eye symptoms. Formulated with patient compliance and...

Int'l Conference on Bioscience, Biochemistry and Bioinformatics

We are pleased to invite and welcome you to attend 2026 16th International Conference on Bioscience, Biochemistry and Bioinformatics (ICBBB 2026) which will be held in Kobe, Japan during January 16-19, 2026. ICBBB 2026 is Co-Organized by Kobe...

BIOCORNEUM® announces the availability of its new dual-action bruise system designed to enhance post-procedure recovery

liposuction, sclerotherapy, and dermal fillers, and includes: Advanced Bruise Cream: A clinically proven, proprietary formula designed to accelerate skin healing and minimize bruising. Enriched with Arnica, Vitamin K, Emu Oil, Vitamin E, and Green...

MTF Biologics and Kolosis BIO introduce Summit Matrix™, expanding solutions for orthopedic and spinal surgeries

Putty. Summit Matrix features NanoLift’s nanocrystalline, plate-like surface, which supports cell activity to promote bone formation. Its hydroxycarbanoapatite composition closely mimics natural bone mineral, enabling optimal resorption and...

First National Campaign Launched by Trauma Intervention Programs (TIP)

clients throughout the West Coast and is committed to compassionate advocacy and aggressive representation. For more information please visit, www.avrek-law-firm.com

Lansinoh® Launched NaturalWave® Double Electric Breast Pump Featuring Exclusive Flutter Technology for Increased Milk Output

16, 2026. The pump will be available through DME (Durable Medical Equipment) providers as an upgrade option. For more information about Lansinoh's full portfolio of products, visit www.lansinoh.com or follow @LansinohUSA on Instagram, TikTok,...

Align Technology Supports Children and Teens With 30 Invisalign® Treatments via Smiles4Canada Program

patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for...

Alamar Biosciences announces the launch of the NULISAqpcr™ AD 5-plex assay, advancing blood-based biomarker detection for Alzheimer’s disease research

from a single blood or plasma sample. The NULISAqpcr AD 5-plex Assay consolidates key biomarkers into a single multiplexed format, delivering unmatched sensitivity, specificity, and ease of use. By incorporating BD-pTau217, Aβ42, NfL, and GFAP, the...

Ad Hoc Analyses Indicate Enhanced Survival Outcomes with VYLOY™ (zolbetuximab) Combined with Chemotherapy When Common Adverse Events Are Properly Managed

is a global life sciences company committed to turning innovative science into value for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our...

PureWay and PPSWG Form New Partnership to Transform Pharmaceutical Waste Management in the U.S.

expertise to support member compliance and improve awareness of existing pharmaceutical disposal options. For more information please visit, www.PPSWG.org.

Clover Begins Phase 2 Clinical Evaluation of a Combination Respiratory Vaccine Targeting RSV, hMPV, and ± PIV3

F (PreF)-Trimer subunit vaccine antigens utilizing Clover's validated Trimer-Tag vaccine technology platform. "The initiation of this Phase 2 trial for our respiratory combination vaccine candidates SCB-1022 (RSV + hMPV) and SCB-1033 (RSV + hMPV +...

FDA Approves New 2-Gram Fibryga® Presentation to Improve Convenience and Precision in Treating Acquired Fibrinogen Deficiency

human plasma-derived fibrinogen concentrate approved for AFD in the U.S. The product's lyophilized powder formulation allows for rapid reconstitution at the point of care, offering a more consistent and targeted alternative to cryoprecipitate,...

Ark Biopharmaceutical Granted China Marketing Authorization for Aizhida in ADHD Treatment

the treatment of ADHD. Each once-daily capsule contains serdexmethylphenidate (SDX), a prodrug of dexmethylphenidate, co-formulated with immediate-release dexmethylphenidate (d-MPH) in a fixed ratio designed to provide both rapid and extended...

Novotech Appoints Anand Tharmaratnam as Chief Executive Officer

in Singapore. The appointment follows a thoughtful and considered process. In early September 2025, Novotech’s former CEO Dr. John Moller informed employees of his intention to step down from the position at the end of last year, after nine years...

Coya Therapeutics Announces Results from an Investigator-Initiated Study Showing Treg Enhancement and Cognitive Stability in Frontotemporal Dementia Patients Treated with Low-Dose IL-2 and CTLA4-Ig

modalities aimed at restoring the anti-inflammatory and immunomodulatory functions of Tregs. Coya’s therapeutic platforms include Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. For more information please visit...

RoslinCT and BOOST Pharma Form Strategic Manufacturing Partnership to Advance Cell Therapy for Osteogenesis Imperfecta

Institutet, a world leader in cell therapy research. Its lead program, BT-101, is a novel MSC-based therapy with high bone-forming capability. Preclinical and clinical studies have demonstrated promising results, including improved bone formation,...

Orum Therapeutics Names Chad May Chief Scientific Officer to Advance Degrader-Antibody Conjugate Programs

a track record of advancing antibody drug conjugates (ADCs), T-cell engagers, and other next-generation therapeutic platforms from concept to clinical evaluation. “Chad has repeatedly demonstrated an ability to take bold scientific concepts and...